Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

10/29/24 4:05:00 PM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $CBLL alert in real time by email

SUNNYVALE, Calif., Oct. 29, 2024 /PRNewswire/ -- Ceribell, Inc. (NASDAQ:CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 7168007. A live and archived webcast of the event will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/.

About Ceribell Inc.

Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is an AI-powered, rapidly deployable point-of-care electroencephalography ("EEG") platform designed to address the unmet needs of patients in the acute care setting. The company is headquartered in Sunnyvale, Calif.

Investor Contact

Brian Johnston or Laine Morgan

Gilmartin Group

[email protected]

Media Contact

Corrie Rose

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/ceribell-to-report-third-quarter-2024-financial-results-on-november-12-2024-302290488.html

SOURCE Ceribell, Inc.

Get the next $CBLL alert in real time by email

Date

Price Target

Rating

Analyst

4/4/2025

$32.00

Buy

Ladenburg Thalmann

11/5/2024

$32.00

Buy

BofA Securities

11/5/2024

$30.00

Buy

Canaccord Genuity

11/5/2024

$32.00

Overweight

JP Morgan

11/5/2024

$31.00

Buy

TD Cowen

11/5/2024

Outperform

William Blair

Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

Chat with this insight

Recent Analyst Ratings for
$CBLL

$CBLL
SEC Filings

CeriBell Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form DEFA14A filed by CeriBell Inc.

SEC Form 144 filed by CeriBell Inc.

$CBLL
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Chao Xingjuan exercised 25,000 shares at a strike of $2.24 and sold $425,000 worth of shares (25,000 units at $17.00) (SEC Form 4)

President and CEO Chao Xingjuan exercised 73,871 shares at a strike of $1.02 and sold $424,000 worth of shares (25,000 units at $16.96), increasing direct ownership by 7% to 776,022 units (SEC Form 4)

President and CEO Chao Xingjuan sold $240,657 worth of shares (15,928 units at $15.11), decreasing direct ownership by 2% to 727,151 units (SEC Form 4)

$CBLL
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Large owner Tpg Gp A, Llc converted options into 3,587,154 shares and bought $6,464,556 worth of shares (380,268 units at $17.00) (SEC Form 4)

Director Tammenoms Bakker Juliet was granted 6,618 shares, converted options into 2,140,600 shares and bought $4,032,978 worth of shares (237,234 units at $17.00) (SEC Form 4)

Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

Chat with this insight

Recent Analyst Ratings for $CBLL

$CBLL SEC Filings

CeriBell Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form DEFA14A filed by CeriBell Inc.

SEC Form 144 filed by CeriBell Inc.

$CBLL Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Chao Xingjuan exercised 25,000 shares at a strike of $2.24 and sold $425,000 worth of shares (25,000 units at $17.00) (SEC Form 4)

President and CEO Chao Xingjuan exercised 73,871 shares at a strike of $1.02 and sold $424,000 worth of shares (25,000 units at $16.96), increasing direct ownership by 7% to 776,022 units (SEC Form 4)

President and CEO Chao Xingjuan sold $240,657 worth of shares (15,928 units at $15.11), decreasing direct ownership by 2% to 727,151 units (SEC Form 4)

$CBLL Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Large owner Tpg Gp A, Llc converted options into 3,587,154 shares and bought $6,464,556 worth of shares (380,268 units at $17.00) (SEC Form 4)

Director Tammenoms Bakker Juliet was granted 6,618 shares, converted options into 2,140,600 shares and bought $4,032,978 worth of shares (237,234 units at $17.00) (SEC Form 4)

Recent Analyst Ratings for
$CBLL

$CBLL
SEC Filings

$CBLL
Insider Trading

$CBLL
Insider Purchases